|
US6217864B1
(en)
|
1996-02-23 |
2001-04-17 |
The Regents Of The University Of California |
Method for targeted degradation of intracellular proteins in vivo or ex vivo
|
|
US6048736A
(en)
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
|
AU4834799A
(en)
|
1998-06-26 |
2000-01-17 |
Regents Of The University Of California, The |
Human az-1 gene, variants thereof and expressed gene products
|
|
US6753154B1
(en)
|
1998-06-26 |
2004-06-22 |
The Regents Of The University Of California |
Human AZU-1 gene, variants thereof and expressed gene products
|
|
US20050153913A1
(en)
|
2001-04-10 |
2005-07-14 |
Kosak Kenneth M. |
Nucleic acid carrier compositions and methods for their synthesis
|
|
US20040038303A1
(en)
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
WO2003103581A2
(en)
|
2002-06-05 |
2003-12-18 |
Genentech, Inc. |
Compositions and methods for liver growth and liver protection
|
|
KR20060015534A
(ko)
|
2003-04-25 |
2006-02-17 |
더 펜 스테이트 리서치 파운데이션 |
성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
|
|
US7329638B2
(en)
|
2003-04-30 |
2008-02-12 |
The Regents Of The University Of Michigan |
Drug delivery compositions
|
|
US7728036B2
(en)
|
2003-05-20 |
2010-06-01 |
Erimos Pharmaceuticals, Llc |
Methods for delivery of catecholic butanes for treatment of tumors
|
|
IL173807A
(en)
*
|
2003-08-22 |
2014-02-27 |
Antipodean Pharmaceuticals Inc |
Antioxidant amphiphilic compounds, histoquinone history and pharmaceutical preparations containing them
|
|
CA2536546C
(en)
|
2003-08-22 |
2012-10-02 |
Antipodean Pharmaceuticals, Inc. |
Mitoquinone derivatives used as mitochondrially targeted antioxidants
|
|
US8067664B2
(en)
|
2003-12-16 |
2011-11-29 |
Genentech, Inc. |
PRO224 gene disruptions, and methods related thereto
|
|
US7393924B2
(en)
|
2004-01-06 |
2008-07-01 |
Franco Vitaliano |
Smart bio-nanoparticle elements
|
|
EP1713325A2
(en)
|
2004-02-12 |
2006-10-25 |
Lexicon Genetics Incorporated |
Gene disruptions, compositions and methods relating thereto
|
|
US20100031378A1
(en)
|
2008-08-04 |
2010-02-04 |
Edwards Joel A |
Novel gene disruptions, compositions and methods relating thereto
|
|
US8128908B2
(en)
|
2004-04-30 |
2012-03-06 |
University Of Florida Research Foundation, Inc. |
Nanoparticles and their use for multifunctional bioimaging
|
|
WO2005112619A2
(en)
|
2004-05-12 |
2005-12-01 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US20060040879A1
(en)
|
2004-08-21 |
2006-02-23 |
Kosak Kenneth M |
Chloroquine coupled nucleic acids and methods for their synthesis
|
|
WO2007040469A2
(en)
|
2005-09-15 |
2007-04-12 |
Kosak Ken M |
Chloroquine coupled compositions and methods for their synthesis
|
|
US20070166281A1
(en)
|
2004-08-21 |
2007-07-19 |
Kosak Kenneth M |
Chloroquine coupled antibodies and other proteins with methods for their synthesis
|
|
US20080051323A1
(en)
|
2004-08-21 |
2008-02-28 |
Kosak Kenneth M |
Chloroquine drug compositions and methods for their synthesis
|
|
AU2005280266A1
(en)
|
2004-08-25 |
2006-03-09 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
EP1817335A2
(en)
|
2004-10-29 |
2007-08-15 |
Genentech, Inc. |
Disruptions of genes encoding secreted proteins, compositions and methods relating thereto
|
|
FR2877571B1
(fr)
*
|
2004-11-05 |
2007-04-13 |
Nanobiotix Sarl |
Nanoparticules pourvues d'un element de ciblage intracellulaire, preparation et utilisations
|
|
US20070066552A1
(en)
|
2005-01-21 |
2007-03-22 |
Introgen Therapeutics, Inc. |
Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
|
|
DK1853631T3
(en)
|
2005-01-24 |
2016-03-29 |
Univ Texas |
Fc-FUSION CONSTRUCTIONS BINDING TO PHOSPHATIDYLSERINE AND THERAPEUTIC APPLICATION THEREOF
|
|
DE602006011127D1
(de)
|
2005-01-27 |
2010-01-28 |
Ocean Nutrition Canada Ltd |
Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
|
|
US20110097330A1
(en)
|
2005-03-11 |
2011-04-28 |
Genentech, Inc. |
Novel Gene Disruptions, Compostitions and Methods Relating Thereto
|
|
US20070014833A1
(en)
|
2005-03-30 |
2007-01-18 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
|
US7638558B2
(en)
|
2005-04-01 |
2009-12-29 |
Intezyne Technologies, Inc. |
Polymeric micelles for drug delivery
|
|
US7725169B2
(en)
|
2005-04-15 |
2010-05-25 |
The Board Of Trustees Of The University Of Illinois |
Contrast enhanced spectroscopic optical coherence tomography
|
|
US20060292099A1
(en)
|
2005-05-25 |
2006-12-28 |
Michael Milburn |
Treatment of eye disorders with sirtuin modulators
|
|
CA2609549A1
(en)
|
2005-05-25 |
2006-11-30 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
|
JP5274248B2
(ja)
|
2005-05-27 |
2013-08-28 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
酸化窒素治療及び医生物的応用のための酸化窒素放出粒子
|
|
CA2610709A1
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
|
US20060286082A1
(en)
|
2005-06-20 |
2006-12-21 |
Kurzweil Raymond C |
Systems and methods for generating biological material
|
|
US20070086949A1
(en)
|
2005-06-20 |
2007-04-19 |
Prasad Paras N |
Method of bioimaging using nanocrystals of fluorescent dyes
|
|
AU2006272586A1
(en)
|
2005-07-27 |
2007-02-01 |
University Of Florida Research Foundation, Inc. |
Use of heat shock to treat ocular disease
|
|
ZA200800970B
(en)
|
2005-08-15 |
2009-10-28 |
Genentech Inc |
Gene disruptions, compositions and methods relating thereto
|
|
JP2009512423A
(ja)
|
2005-09-12 |
2009-03-26 |
ザ・ジョンズ・ホプキンス・ユニバーシティ |
抗血管新生の活性を有する組成物及びその使用
|
|
US9220788B2
(en)
|
2009-06-17 |
2015-12-29 |
Nanopharmaceuticals Llc |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
|
|
US20090022806A1
(en)
|
2006-12-22 |
2009-01-22 |
Mousa Shaker A |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
|
|
WO2008048288A2
(en)
|
2005-11-09 |
2008-04-24 |
Montana State University |
Novel nanoparticles and use thereof
|
|
EP1962584A2
(en)
|
2005-11-21 |
2008-09-03 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US20110172826A1
(en)
|
2005-12-14 |
2011-07-14 |
Amodei Dario G |
Device including altered microorganisms, and methods and systems of use
|
|
US8682619B2
(en)
|
2005-12-14 |
2014-03-25 |
The Invention Science Fund I, Llc |
Device including altered microorganisms, and methods and systems of use
|
|
EP1981970A4
(en)
|
2006-01-11 |
2009-10-21 |
Technion Res & Dev Foundation |
TISSUE CONSTRUCTION TISSUE TREATMENT DERIVED FROM A HUMAN EMBRYONIC STEM CELL
|
|
US20080311107A1
(en)
|
2006-02-17 |
2008-12-18 |
Genetech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
|
JP2009528294A
(ja)
|
2006-02-23 |
2009-08-06 |
エリモス・ファーマスーティカルズ・エルエルシー |
インフルエンザウイルス感染症の治療方法
|
|
EP2018186A2
(en)
|
2006-04-11 |
2009-01-28 |
Ordway Research Institute, Inc. |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
|
WO2007120818A2
(en)
|
2006-04-12 |
2007-10-25 |
Massachusetts Institute Of Technology |
Compositions and methods for inhibiting adhesions
|
|
US8449915B1
(en)
*
|
2006-04-17 |
2013-05-28 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
CA2649387A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US20080187487A1
(en)
|
2006-05-03 |
2008-08-07 |
Gustavo Larsen |
Methods for producing multilayered particles, fibers and sprays and methods for administering the same
|
|
US7671095B2
(en)
|
2006-05-31 |
2010-03-02 |
The Trustees Of The Boston University |
Films and particles
|
|
EP2032623A2
(en)
|
2006-05-31 |
2009-03-11 |
The Trustees of the Boston University |
Films and particles
|
|
WO2007141050A2
(de)
|
2006-06-08 |
2007-12-13 |
Bayer Schering Pharma Aktiengesellschaft |
Funktionalisierte, feste polymernanopartikel für diagnostische und therapeutische anwendungen
|
|
US8501478B2
(en)
|
2006-06-15 |
2013-08-06 |
University Of Cincinnati |
Trehalose click polymers for delivery of biologically active molecules
|
|
WO2008013952A2
(en)
|
2006-07-27 |
2008-01-31 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
|
|
AU2007305220A1
(en)
|
2006-07-28 |
2008-04-10 |
Genentech, Inc. |
Knockout mice for different genes and their use for gene characterizatio
|
|
WO2008019357A2
(en)
|
2006-08-07 |
2008-02-14 |
Ironwood Pharmaceuticals, Inc. |
Indole compounds
|
|
EP2076252B1
(en)
|
2006-10-02 |
2014-04-02 |
Erimos Pharmaceuticals LLC |
Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
|
|
JP2010515428A
(ja)
|
2006-11-14 |
2010-05-13 |
ジェネンテック, インコーポレイテッド |
新規の遺伝子破壊、組成物、およびそれに関連する方法
|
|
WO2008091465A2
(en)
|
2006-12-21 |
2008-07-31 |
Wayne State University |
Peg and targeting ligands on nanoparticle surface
|
|
ES2535005T3
(es)
|
2006-12-22 |
2015-05-04 |
Nanopharmaceuticals Llc |
Formulaciones de nanopartículas y de polímeros para análogos, antagonistas y formulaciones de la hormona tiroidea, y usos de los mismos
|
|
US8507434B2
(en)
|
2007-01-03 |
2013-08-13 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
|
EP2114141A2
(en)
|
2007-01-10 |
2009-11-11 |
University of Florida |
Compounds and methods for treatment of alpha-1 antitrypsin deficiency
|
|
JP2010516239A
(ja)
|
2007-01-18 |
2010-05-20 |
スオメン プナイネン リスティ,ヴェリパルベル |
細胞の産生に対する新規方法および試薬
|
|
WO2008091888A2
(en)
|
2007-01-23 |
2008-07-31 |
Lexicon Pharmaceuticals, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US9056129B2
(en)
*
|
2007-02-09 |
2015-06-16 |
Northeastern University |
Precision-guided nanoparticle systems for drug delivery
|
|
WO2008106646A2
(en)
|
2007-03-01 |
2008-09-04 |
Introgen Therapeutics, Inc |
Methods and formulations for topical gene therapy
|
|
US20080299177A1
(en)
|
2007-06-06 |
2008-12-04 |
Biovaluation & Analysis, Inc. |
Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
|
|
US20080294089A1
(en)
|
2007-06-06 |
2008-11-27 |
Biovaluation & Analysis, Inc. |
Dendritic Polymers for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
|
|
WO2009009591A2
(en)
|
2007-07-09 |
2009-01-15 |
Kansas State University Research Foundation |
Use of cells to facilitate targeted delivery of nanoparticle therapies
|
|
US20090018078A1
(en)
|
2007-07-09 |
2009-01-15 |
Vinod Labhasetwar |
Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same
|
|
US20110038939A1
(en)
|
2007-07-16 |
2011-02-17 |
Northeastern University |
Therapeutic stable nanoparticles
|
|
BRPI0815416A2
(pt)
|
2007-08-15 |
2014-10-21 |
Amunix Inc |
Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
|
|
AU2008296012A1
(en)
|
2007-09-07 |
2009-03-12 |
Gencia Corporation |
Mitochondrial compositions and uses thereof
|
|
US9034387B2
(en)
|
2007-10-03 |
2015-05-19 |
Jawaharlal Nehru Centre For Advanced Scientific Research |
Intrinsically fluorescent carbon nanospheres and a process thereof
|
|
JP5484339B2
(ja)
|
2007-10-05 |
2014-05-07 |
ウェイン ステート ユニバーシティー |
合成物の持続的な放出のためのデンドリマー
|
|
US20110045081A1
(en)
*
|
2007-10-12 |
2011-02-24 |
Benedikt Steitz |
Magnetic, paramagnetic and/or superparamagnetic nanoparticles
|
|
ES2744834T3
(es)
|
2007-11-05 |
2020-02-26 |
Univ Vanderbilt |
Nanopartículas degradables multifuncionales con control sobre el tamaño y las funcionalidades
|
|
US20110274620A1
(en)
|
2007-11-05 |
2011-11-10 |
Harth Eva M |
Multifunctional degradable nanoparticles with control over size and functionalities
|
|
US20090148384A1
(en)
|
2007-12-10 |
2009-06-11 |
Fischer Katrin |
Functionalized, solid polymer nanoparticles comprising epothilones
|
|
US8563066B2
(en)
|
2007-12-17 |
2013-10-22 |
New World Pharmaceuticals, Llc |
Sustained release of nutrients in vivo
|
|
US20090169521A1
(en)
|
2007-12-31 |
2009-07-02 |
Technion Research & Development Foundation Ltd. |
Vascularized cardiac tissue and methods of producing and using same
|
|
EP2278999B1
(en)
|
2008-04-21 |
2025-01-29 |
Dompé farmaceutici S.p.A. |
Auris formulations for treating otic diseases and conditions
|
|
US8324333B2
(en)
|
2008-06-05 |
2012-12-04 |
Wisconsin Alumni Research Foundation |
Anionic charge-dynamic polymers for release of cationic agents
|
|
MX2011000545A
(es)
|
2008-07-14 |
2011-02-24 |
Otonomy Inc |
Composiciones de liberacion controlada para la modulacion de apoptosis y metodos para el tratamiento de trastornos oticos.
|
|
US8496957B2
(en)
|
2008-07-21 |
2013-07-30 |
Otonomy, Inc |
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
|
|
US8399018B2
(en)
|
2008-07-21 |
2013-03-19 |
Otonomy, Inc. |
Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
|
|
US8784870B2
(en)
|
2008-07-21 |
2014-07-22 |
Otonomy, Inc. |
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
|
|
CN102105133B
(zh)
|
2008-07-21 |
2015-06-17 |
奥德纳米有限公司 |
控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法
|
|
JP5529874B2
(ja)
|
2008-09-25 |
2014-06-25 |
インヴィーヴォ セラプーティクス コーポレーション |
脊髄の損傷、炎症および免疫疾患に用いられる局所的に放出を制御しうる治療薬
|
|
AU2009302217A1
(en)
|
2008-10-09 |
2010-04-15 |
Northeastern University |
Multifunctional self-assembling polymeric nanosystems
|
|
US8256233B2
(en)
|
2008-10-31 |
2012-09-04 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
|
US8563012B2
(en)
|
2008-10-31 |
2013-10-22 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
|
US8731842B2
(en)
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
|
US8603494B2
(en)
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
|
US8798933B2
(en)
|
2008-10-31 |
2014-08-05 |
The Invention Science Fund I, Llc |
Frozen compositions and methods for piercing a substrate
|
|
US8603495B2
(en)
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
|
US9050251B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
|
US9060931B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
|
CA2742986C
(en)
|
2008-11-07 |
2015-03-31 |
Triact Therapeutics, Inc. |
Use of catecholic butane derivatives in cancer therapy
|
|
WO2010054326A2
(en)
|
2008-11-07 |
2010-05-14 |
The General Hospital Corporation |
C-terminal fragments of glucagon-like peptide-1 (glp-1)
|
|
US9308214B2
(en)
*
|
2008-11-12 |
2016-04-12 |
Mitotech S.A. |
Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations
|
|
AU2009330458B2
(en)
|
2008-12-22 |
2013-08-22 |
Otonomy, Inc. |
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
|
|
US8273373B2
(en)
|
2008-12-30 |
2012-09-25 |
Case Western Reserve University |
Photocrosslinked biodegradable hydrogel
|
|
WO2010105058A1
(en)
|
2009-03-11 |
2010-09-16 |
Northeastern University |
Low-aspect ratio nanostructures
|
|
WO2010111517A1
(en)
|
2009-03-25 |
2010-09-30 |
Northeastern University |
Stable polyelectrolyte coated nanoparticles
|
|
EP2248903A1
(en)
|
2009-04-29 |
2010-11-10 |
Universitat Autònoma De Barcelona |
Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
|
|
US20120184495A1
(en)
|
2009-06-12 |
2012-07-19 |
Amrita Vishwa Vidyapeetham University Kerala |
Targeted nano-photomedicines for photodynamic therapy of cancer
|
|
US20100331819A1
(en)
|
2009-06-24 |
2010-12-30 |
Abbott Cardiovascular Systems Inc. |
Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy
|
|
KR101609641B1
(ko)
|
2009-07-28 |
2016-04-07 |
삼성전자주식회사 |
무선통신 시스템에서 자동 이웃 관계 구성 및 최적화를 위한 장치 및 방법
|
|
US20130017265A1
(en)
*
|
2009-12-16 |
2013-01-17 |
Massachusetts Institute Of Technology |
Particles for multiple agent delivery
|
|
US20110203013A1
(en)
|
2010-02-17 |
2011-08-18 |
Pioneer Hi Bred International Inc |
Delivering compositions of interest to plant cells
|
|
WO2011109600A1
(en)
|
2010-03-05 |
2011-09-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for modifying the glycosylation pattern of a polypeptide
|
|
SG184128A1
(en)
|
2010-03-17 |
2012-10-30 |
Nanomed Devices Inc |
A built-in non-verbal instructional device integratable to applicators
|
|
US20130164851A1
(en)
|
2010-03-26 |
2013-06-27 |
Alnylam Pharmaceuticals, Inc. |
Gene amplification and transfection methods and reagents related thereto
|
|
WO2011130624A2
(en)
|
2010-04-16 |
2011-10-20 |
Immune Disease Institute, Inc. |
Sustained polypeptide expression from synthetic, modified rnas and uses thereof
|
|
ES2952389T3
(es)
|
2010-06-04 |
2023-10-31 |
Hough Ear Inst |
Composición y método de regeneración o reemplazo de células ciliadas sensoriales del oído interno
|
|
US9284188B2
(en)
|
2010-09-03 |
2016-03-15 |
The Regents Of The University Of California |
Cytosolic delivery of materials with endosome-disrupting colloids
|
|
US9040481B2
(en)
|
2010-11-02 |
2015-05-26 |
The General Hospital Corporation |
Methods for treating steatotic disease
|
|
AR083705A1
(es)
|
2010-11-04 |
2013-03-13 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
CA2819635A1
(en)
|
2010-12-01 |
2012-06-07 |
Spinal Modulation, Inc. |
Directed delivery of agents to neural anatomy
|
|
US9642925B2
(en)
|
2010-12-07 |
2017-05-09 |
Sanford Research/USD |
Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use
|
|
WO2012092569A2
(en)
|
2010-12-31 |
2012-07-05 |
Selecta Biosciences, Inc. |
Compositions comprising immunostimulatory nucleic acids and related methods
|
|
US9428565B2
(en)
|
2011-01-31 |
2016-08-30 |
The General Hospital Corporation |
Treatment and bioluminescent visualization using multimodal TRAIL molecules
|
|
US20130136786A1
(en)
|
2011-02-10 |
2013-05-30 |
Sanford-Burnham Medical Research Institute |
Long non-coding rna spry4-it1 as a diagnostic and therapeutic agent
|
|
WO2012135848A2
(en)
|
2011-04-01 |
2012-10-04 |
Scott & White Healthcare |
Melatonin-based treatment and diagnosis of bile duct disease
|
|
US9140698B2
(en)
|
2011-04-06 |
2015-09-22 |
The Board Of Regents Of The University Of Texas System |
Modulating bacterial MAM polypeptides in pathogenic disease
|
|
US20120263793A1
(en)
|
2011-04-14 |
2012-10-18 |
Franco Vitaliano |
Bio-nano-plasmonic elements and platforms
|
|
WO2012142511A2
(en)
|
2011-04-15 |
2012-10-18 |
Md Matrix Health Llc Dba Md Matrix Health Inc |
Orthomolecular compositions and their use in stabilizing the extracellular matrix
|
|
CN103501812A
(zh)
|
2011-04-29 |
2014-01-08 |
西莱克塔生物科技公司 |
用于过敏症治疗的致耐受性合成纳米载体
|
|
US9901616B2
(en)
|
2011-08-31 |
2018-02-27 |
University Of Georgia Research Foundation, Inc. |
Apoptosis-targeting nanoparticles
|
|
US10416167B2
(en)
|
2012-02-17 |
2019-09-17 |
University Of Georgia Research Foundation, Inc. |
Nanoparticles for mitochondrial trafficking of agents
|
|
US20150374714A1
(en)
|
2013-02-11 |
2015-12-31 |
University Of Georgia Research Foundation, Inc. |
Generation of functional dendritic cells
|